Background:
Introduction
Pleiotropy occurs when a genetic locus is associated with more than one trait (1) and has been observed across multiple phenotypes, including cancer (2) (3) (4) (5) . These shared associations suggest potential common biologic pathways. One example of pleiotropy occurs at the TERT gene region. Germline mutations in TERT are associated with telomere length (6) , but have also been associated with phenotypes, such as pulmonary fibrosis (7), red blood cell count (8) , and aplastic anemia (9) . TERT mutations have also been identified across multiple cancer types (10), including breast (11), prostate (12) , pancreatic (13), glioma (14) , and lung (15) (16) (17) . Identifying pleiotropy is a useful tool for genetic association studies to discover common biologic mechanisms, shared genetic architecture across diseases, and potentially new opportunities for therapeutic targets.
Cross-cancer pleiotropic analysis has been conducted for several cancer types (2, 3, 5, 18) , including lung cancer (4, 5) . Pleiotropic analysis of lung cancer has identified associations with LSP1, ADAM15/THBS3, CDKN2B-AS1, and BRCA2 genes in populations of predominantly European ancestry (4, 5) . However, recent studies have shown the non-transferability of risk alleles across racial/ethnic groups (19, 20) . It remains unknown whether pleiotropic associations of prior cancer variants are generalizable and associated with lung cancer among African American individuals. Furthermore, only a few studies (21) have accounted for either pleiotropy arising from variants in linkage disequilibrium or the ancestry of the discovery population. We used genome-wide genotyping data from five African American study populations to identify pleiotropic associations with lung cancer, incorporating variants in linkage disequilibrium and accounting for ancestry.
Methods

Study population
African American lung cancer cases and controls were selected from five study sites: the Women's Epidemiology of Lung Disease Study; and Exploring Health, Ancestry and Lung Epidemiology Study. A detailed description of each study has been previously reported (22) . All studies were approved by the Institutional Review Board at each institution and written informed consent was obtained from all participants.
Genotyping, quality control, and imputation
Samples were previously genotyped (22) on the Illumina Human Hap 1M Duo array at the NCI Cancer Genomics Research Laboratory (CGR) in the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute. Genotyping data underwent strict quality control (Supplemental Figure 1) . Briefly, single nucleotide polymorphisms (SNPs) were excluded if they were non-autosomal, had a MAF <1%, <95% genotyping efficiency, or a Hardy-Weinberg Equilibrium (HWE) p-value <1x10 -6 . Individuals were excluded if they had a <95% genotyping efficiency. Pairwise identity-by-descent was examined to identify related individuals; for each genetically related pair, the individual with the lowest genotyping efficiency was excluded (N=147). No individuals were excluded due to inconsistencies between reported and genetic sex, but four individuals with an "unknown" reported sex were filled in based on the calculated genetic sex. All quality control filtering was applied using PLINK (23) .
Missing genotypes were imputed using IMPUTE2 (24) , with pre-phasing performed using SHAPEIT (25) (26) (27) . Haplotypes from the cosmopolitan 1000 Genomes phase 3 population consisting of 2,504 individuals from 26 countries were used as a reference population. SNPs imputed with low certainty were excluded based on an info score <0.4, MAF<0.01, and HWE pvalue <1x10 -5 .
Ancestry estimation
Supervised admixture analysis was performed using ADMIXTURE software (28) to obtain global estimates of African and European ancestry for all individuals. Admixture analysis was performed on observed genotypes merged with the CEU (CEPH Utah residents with
Northern and Western European ancestry) and YRI (Yoruba from Ibadan, Nigeria) HapMap reference populations (29), and pruned to a set of unlinked variants (window size = 50, step size = 10, r 2 > 0.1). A total of 140,591 variants remained for supervised (k=2) admixture analysis.
Selection of variants for pleiotropic analysis
All variants previously associated with any cancer type were identified from the NHGRI-EBI GWAS catalog as of April 2016. Manual review excluded studies in which the outcome was not risk (e.g. survival, prognosis, toxicity, relapse). Studies assessing interactions were also excluded. SNPs from each of the remaining studies were aggregated into a single list, hereafter referred to as "reported SNPs."
Because genotyping arrays are designed to capture genome-wide variation using as few SNPs as possible, the majority of reported associations are rarely causal, but rather correlated (or in linkage disequilibrium, LD) with the true causal variant (30, 31 
Statistical analysis
Logistic regression was performed for each additively coded risk allele using SNPTEST to account for imputation probabilities (35) . Age, sex, smoking status (current/former/never), global African ancestry, and study site were included as covariates in the logistic regression models. A Benjamini-Hochberg false discovery rate (FDR) correction was applied to p-values to account for multiple testing. Statistical significance was defined as an FDR-corrected p-value < 0.1. Exploratory strata-specific analyses were conducted by histologic subtype, smoking status (ever/never), and sex. A meta-analysis was also conducted summarizing results from each study (adjusting for age, sex, smoking status, and global African ancestry) using a fixed effect model in METAL (36) .
Results
Descriptive Characteristics
A total of 4,253 African American individuals remained following quality control, with 1,410 lung cancer cases and 2,843 controls (Table 1) . Forty-five percent of all individuals were male and the mean age at diagnosis was 58 years. Lung cancer cases were on average five years older than controls. Among cases, 55% of participants were current smokers and 37% were former smokers, while 43% of controls were never smokers. The median global African ancestry was similar among cases and controls (84% and 83%, respectively). The most frequent histologic cell type among cases was adenocarcinoma (45%), followed by squamous cell carcinoma (24%).
Descriptive characteristics by study and case/control status are presented in Table 1 .
Variant Selection
A total of 266 unique studies were extracted from the NHGRI-EBI GWAS Catalog based on the search term "neoplasm." Forty-six studies were excluded after manual review (see Methods), resulting in 220 studies reporting associations for 959 unique SNPs ("reported SNPs"). Seventy-four percent (163 out of 220) of studies were conducted in European-descent populations, followed by 26% (57 of 220) in Asian-descent populations ( Table 2 ). The admixed Latino/a and African American populations accounted for only 3% and 5% of prior GWAS cancer studies, respectively (Table 2) . Of all reported SNPs, 629 were directly observed in the genotype data and an additional 294 were imputed. Thirty-six reported SNPs were not present in the 1000 Genomes reference populations used for LD-based selection of SNPs and were dropped from analysis. Application of the PLINK pairwise LD estimation method (r 2 >0.6 and +/-100kb) to all reported SNPs increased the number of SNPs from 959 to 39,010 (Table 2) .
Logistic Regression Analysis
Among the 39,010 selected SNPs, 1,772 were neither observed nor imputed in our
African American population and 280 SNPs failed to meet post-imputation quality control filtering, resulting in 36,958 selected SNPs for analysis. Logistic regression analysis revealed 40
SNPs that were significantly associated with lung cancer risk ( Figure 1 and Table 3 observed when study sites were combined using fixed effect meta-analysis (data not shown).
Exploratory Stratified Analyses
To identify histologic subtype-specific associations for lung cancer risk, we examined adenocarcinoma cases (N=632) and squamous cell carcinoma cases (N=337) separately. No Table 2 ). No p-values were statistically significant after FDR correction in never smokers (Supplemental Figure 4) .
Discussion
The present analysis sought to identify cross-cancer pleiotropic genetic associations for lung cancer risk in African Americans. The two most significant associations were on chromosome 15q25.1 and 5p15.33, both of which have been previously associated with lung cancer in African Americans (37) (38) (39) and recently validated in a non-independent African American consortium study (22) that included cases and controls utilized in the present study.
We also identified three novel associations on chromosomes 5q14.3, 16q22.2, and 17q12.
Chromosome 16q22.2 was also observed among ever smokers and an additional region on 12q21.32 was specific to women. Despite not meeting our threshold for statistical significance, there was suggestive evidence for an association of 5p15.33 and 15q25.1 among never smokers.
These results are consistent with prior research indicating 5p15.33 is associated with lung cancer risk among never smokers (15, 40) and contribute to the ongoing debate as to whether 15q25.1 is directly associated with lung cancer or mediated by smoking (41-45).
Excluding established risk loci 5p15.33 and 15q25.1, the most significant association was for rs7186207 on chromosome 16q22.2 (FDR-corrected p-value = 0.04). All four SNPs in this region (rs7186207, rs8051239, rs7195958, and rs3213422) had similar odds ratios and were in strong LD (r 2 > 0.68) with each other in both African (YRI and ASW) and European (CEU) 1000
Genomes reference populations (46) . Given the high degree of correlation between variants, it is unsurprising that risk allele frequencies were similar among the four SNPs, ranging from 0.56 to 0.62. None of the four SNPs were among the reported SNPs extracted from the GWAS Catalog, but were selected because of their strong LD (r 2 = 0.75-0.78) with rs12597458, a variant previously associated with prostate cancer risk (12) . The 16q22.2 region has been previously associated with prostate cancer (47) . SNPs rs7186207, rs8051239, and rs7195958 are intergenic and located between PKD1L3 and DHODH and do not appear to be located at sites with regulatory potential based on histone modification marks (Supplemental Figure 5) . However, GTEx data (48) reveals rs7186207 is significantly associated with DHODH gene expression in lung (p-value=2.1x10 -7 , Figure 2 ) and other tissues. The remaining SNP at this locus, rs3213422, is located within the first intron of DHODH (Supplemental Figure 5) and encodes a missense mutation, though SIFT (49) and PolyPhen-2 (50) both predict the mutation to be tolerated/benign. Given its close proximity to the exon boundary within DHODH, variation at rs3213422 could also affect exon splicing and GTEx data (48) reveals rs3213422 is a splice QTL for DHODH in aortic artery tissue (p-value=2.7x10 -6 ). ENCODE data reveal H3K4me3 and H3K27ac markers surrounding rs3213422, indicative of active promoters and regulatory elements, as well as evidence for transcription factor binding (Supplemental Figure 5 ).
The DHODH, or dihydroorotate dehydrogenase, gene encodes a 43-kDa enzymatic protein localized to the inner mitochondrial membrane, where it interacts with the mitochondrial respiratory chain and acts as a rate-limiting step in de novo pyrimidine biosynthesis (51-53).
Mutations within DHODH have been linked with Miller Syndrome, a recessive disorder characterized by malformations of the limbs and eyes, among other symptoms (54) (55) (56) (57) . DHODH has also been investigated for a role in cancer, including melanoma (58) and acute myeloid leukemia (59) and decreased expression of DHODH was associated with breast cancer risk (60) .
Several other studies have examined the utility of DHODH inhibitors in cancer by inducing cell cycle arrest and apoptosis in cancer cells (59, (61) (62) (63) (64) (65) (66) . While DHODH has not been previously associated with lung cancer risk, the abundance of biological evidence for its pleiotropic role in cancer gives credibility to the association.
We identified significant associations on chromosomes 5q14.3 and 17q12. Chromosome 5q14.3 SNP rs336958 is an intronic variant for HAPLN1, hyaluronan and proteoglycan link protein 1, which has been shown to play a role in cell adhesion and extracellular matrix structure.
SNP rs336958 is in LD (r 2 =0.97) with rs4466137 which has been associated with prostate cancer risk (67) . The larger 5q14.3 region has also been associated with prostate cancer (12), breast cancer (7), and Wilms tumors (68) Of the SNPs previously reported to have a pleiotropic association with lung cancer (4, 5), two were not present in our current analysis. The remaining three SNPs (rs3817198, rs1057941, and rs4072037) were not significantly associated with lung cancer risk in our African American population. Both previous lung cancer pleiotropy studies (4, 5) utilized predominantly Europeandecent populations; thus, failure to replicate could represent population-specific effects.
However, the minor allele frequency of rs3817198 and rs1057941 is higher in European versus African populations (rs3817198: 30% vs. 12%, respectively; rs1057941: 44% vs. 12%, respectively), which could result in reduced statistical power to detect these associations in our
African American study population.
Previous pleiotropy studies have failed to consider differences in LD structure between racial/ethnic groups. Such considerations are important given recent publications noting the nontransferability of genetic risk predictions across diverse populations (19, 20) . In the present analysis, a notable strength is our effort to expanded the list of reported SNPs by considering the LD structure of the racial/ethnic population of the discovery population, thus removing the assumption that the reported SNP has the same correlation structure, and therefore, tagging ability, with the causal SNP in all racial/ethnic groups. Importantly, it was through consideration of LD structure that the present study was able to identify novel lung cancer risk associations, as only two of the most significant SNPs (rs2853672 on 5p15.33 and rs1051730 on 15q25.1) were among the list of reported SNPs extracted from the GWAS catalog.
It is important to note that the present study is not independent of the study by Zanetti et al. as our cases and controls are a subset of the individuals in the Zanetti et al study. By restricting the analysis to SNPs with a priori evidence to examine cross-cancer pleiotropic associations, our study was able to identify novel lung cancer risk loci that may have been missed due to stringent multiple test corrections required in genome-wide association studies.
Stratification by sex and smoking status revealed strong associations among women and ever smokers, suggesting the observed associations among all lung cancer cases and controls may be driven by these two subgroups. It remains to be determined whether the observed associations among women but not men represent a true biological phenomenon or are simply an artifact of reduced statistical power among men.
With our large sample size of African Americans and consistent results across the pooled and meta-analyses, we have identified several novel regions associated with lung cancer risk.
Our findings highlight the need for a national effort dedicated to prioritizing research in diverse populations for future replication and fine mapping in African American lung cancer cases and controls to better understand the underlying mechanisms contributing to these pleiotropic signals.
Functional studies should be performed to elucidate the pleiotropic effect of these associations across cancer types and identify common biological pathways across phenotypes that may lead to therapeutic targets for lung cancer. Data are from GTEx Portal (48).
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